SCHEMBL12379546

SCHEMBL12379546

Cc1ccc(C(=NOC(=O)CC2CC3C4CCc5cc(OCc6ccccc6)ccc5C4CC[C@]3(C)C2=O)c2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 10/20 0.51
USP2 O75604 1/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
HRH3 Q9Y5N1 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
STS P08842 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
ESR1 P03372 2/20 0.39
LMNA P02545 1/20 0.38
NR3C1 P04150 1/20 0.38
SHBG P04278 1/20 0.38
FYN P06241 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADRA2C P18825 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12418540 0.91 HSD17B1 (0.53) HSD17B1HRH3KDM4EALDH1A1CYP3A4
SCHEMBL12379513 0.90 HSD17B1 (0.64) HSD17B1MAPTMAPK1STSCYP3A4
SCHEMBL12379510 0.82 HSD17B1 (0.76) HSD17B1USP2MAPTMAPK1HRH3
SCHEMBL12418333 0.82 HSD17B1 (0.63) HSD17B1USP2MAPTMAPK1HRH3
SCHEMBL12379505 0.81 USP2 (0.64) HSD17B1USP2MAPTMAPK1HRH3
SCHEMBL2292483 0.74 MAPT (0.63) HSD17B1USP2MAPTMAPK1HRH3
SCHEMBL12379440 0.74 MAPT (0.63) HSD17B1USP2MAPTMAPK1HRH3
SCHEMBL5849823 0.74 MAPT (0.61) HSD17B1USP2MAPTMAPK1HRH3
SCHEMBL12192118 0.74 MAPT (0.59) USP2MAPTMAPK1HRH3STS
SCHEMBL1977073 0.73 MAPT (0.64) HSD17B1USP2MAPTMAPK1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003783-B2 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer STERIX LIMITED (GB) 2011-08-23 US disclosed